- EBS has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $8.1 million.
- EBS has traded 31,844 shares today.
- EBS is trading at a new lifetime high.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in EBS with the Ticky from Trade-Ideas. See the FREE profile for EBS NOW at Trade-Ideas More details on EBS: Emergent BioSolutions Inc., a specialty pharmaceutical company, develops, manufactures, and commercializes specialized products for use in biodefense and commercial markets in the United States and internationally. EBS has a PE ratio of 37. Currently there are 2 analysts that rate Emergent BioSolutions a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Emergent BioSolutions has been 257,400 shares per day over the past 30 days. Emergent BioSolutions has a market cap of $1.2 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.94 and a short float of 11.4% with 15.23 days to cover. Shares are up 17.7% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.